Exemplis Discimus 2012, 156(2):93-102

Lorem ipsum dolor sit amet, consectetuer adipiscing elit.

Hiram Tao-ni, Rhynna Loren, Zoya Samuul, Mebba Lars, Koon Glopio, Zack Armada
Faculty of Biological hematology, Teaching Hospital of Yaga-Minor, Iego Republic

Background: Proin ipsum enim, pellentesque in, ultrices in, aliquet a, pede. Mauris eu enim at risus sollicitudin egestas. Cras sapien purus, pulvinar quis, laoreet eget, scelerisque eleifend, sapien. Curabitur ac lectus id magna ullamcorper faucibus. Suspendisse accumsan velit non nisi blandit dapibus.. Aliquam mauris arcu, porttitor ut, dignissim ut, tristique quis, mi. Nam tellus quam, pellentesque in, suscipit vulputate, gravida varius, odio. Proin velit sem, volutpat ac, interdum vel, vulputate non, lacus.

Methods: Ut et turpis non purus consectetuer luctus.. Vivamus vitae leo vel urna molestie placerat. Etiam ligula nunc, commodo eu, bibendum a, consequat eu, nisl. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Proin nulla diam, commodo ac, cursus quis, ullamcorper et, diam. Morbi odio mi, ullamcorper ut, aliquam quis, lacinia sed, pede. Etiam nisl orci, facilisis sit amet, auctor sed, adipiscing eu, lorem. Cras metus diam, convallis non, adipiscing eget, semper in, odio.

Keywords: Pellentesque a quam

Received: November 2, 2011; Accepted: May 17, 2012; Prepublished online: June 14, 2012; Published: June 1, 2012 

Open full article

References

  1. Kolarova H, Tomankova K, Bajgar R, Kolar P, Kubinek R. Photodynamic and sonodynamic treatment by phthalocyanine on cancer cell lines. Ultrasound Med Biol 2009;35:1397-404. Go to original source... Go to PubMed...
  2. Rob ertson CA, Evans DH, Abrahamse H. Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT. J Photochem Photobiol B 2009;96:1-8. Go to original source... Go to PubMed...
  3. Olivo M , Bhuvaneswari R, Lucky SS, Dendukuri N and Soo-Ping Thong P. Targeted Therapy of Cancer Using Photodynamic Therapy in Combination with Multi-faceted Anti-Tumor Modalities. Pharmaceuticals 2010;3:1507-29. Go to original source...
  4. Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson BC, Golab J. Photodynamic therapy of cancer: an update. CA Cancer J Clin 2011;61:250-81. Go to original source... Go to PubMed...
  5. Juarranz A, Jaén P, Sanz-Rodríguez F, Cuevas J, González S. Photodynamic therapy of cancer. Basic principles and applications. Clin Transl Oncol 2008;10:148-54. Go to original source... Go to PubMed...
  6. O'Connor AE, Gallagher WM, Byrne AT. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. Photochem Photobiol 2009;85:1053-74. Go to original source... Go to PubMed...
  7. Nowis D, Stokłosa T, Legat M, Issat T, Jakóbisiak M, Goł±b J. The influence of photodynamic therapy on the immune response. Photodiagnosis and Photodynamic Therapy 2005;2:283-98. Go to original source...
  8. Gollnick SO, Brackett CM. Enhancement of anti-tumor immunity by photodynamic therapy. Immunol Res 2010;46:216-226. Go to original source... Go to PubMed...
  9. Jemec GBE. Photodynamic therapy. In: Jemec GBE, Kemeny L, Miech D, editors. Non-Surgical Treatment of Keratinocyte Skin Cancer. Heidelberg, Dordrecht, London, New York: Springer; 2010. p.133-5.
  10. Ryter SW, Gomer CJ. Nuclear factor kappa B binding activity in mouse L1210 cells following photofrin II-mediated photosensitization. Photochem Photobiol 1993;58:753-6. Go to original source... Go to PubMed...
  11. Legrand-Poels S, Bours V, Piret B, Pflaum M, Epe B, Rentier B, Piette J. Transcription factor NF-kappa B is activated by photosensitization generating oxidative DNA damages. J Biol Chem 1995;270:6925-34. Go to original source... Go to PubMed...
  12. Matroule JY, Bonizzi G, Morli?re P, Paillous N, Santus R, Bours V, Piette J. Pyropheophorbide-a methyl ester-mediated photosensitization activates transcription factor NF-kappaB through the interleukin-1 receptor-dependent signaling pathway. J Biol Chem 1999;274:2988- 3000. Go to original source... Go to PubMed...
  13. Granville DJ, Carthy CM, Jiang H, Levy JG, McManus BM, Matroule JY, Piette J, Hunt DW. Nuclear factor-kappaB activation by the photochemotherapeutic agent verteporfin. Blood 2000;95:256-62. Go to PubMed...
  14. Kick G, Messer G, Goetz A, Plewig G, Kind P. Photodynamic therapy induces expression of interleukin 6 by activation of AP-1 but not NF-kappa B DNA binding. Cancer Res 1995;55:2373-9. Go to PubMed...
  15. Gollnick SO, Lee BY, Vaughan L, Owczarczak B, Henderson BW. Activation of the IL-10 gene promoter following photodynamic therapy of murine keratinocytes. Photochem Photobiol 2001a;73:170-7. Go to original source... Go to PubMed...
  16. Wild PJ, Krieg RC, Seidl J, Stoehr R, Reher K, Hofmann C, Louhelainen J, Rosenthal A, Hartmann A, Pilarsky C, Bosserhoff AK, Knuechel R. RNA expression profiling of normal and tumor cells following photodynamic therapy with 5-aminolevulinic acid-induced protoporphyrin IX in vitro. Mol Cancer Ther 2005;4:516-28. Go to original source... Go to PubMed...
  17. Ruhdorfer S, Sanovic R, Sander V, Krammer B, Verwanger T. Gene expression profiling of the human carcinoma cell line A-431 after 5-aminolevulinic acid-based photodynamic treatment. Int J Oncol 2007;30:1253-62. Go to original source... Go to PubMed...
  18. Sanovic R, Krammer B, Grumboeck S, Verwanger T. Time-resolved gene expression profiling of human squamous cell carcinoma cells during the apoptosis process induced by photodynamic treatment with hypericin. Int J Oncol 2009;35:921-39. Go to PubMed...
  19. Gollnick SO, Evans SS, Baumann H, Owczarczak B, Maier P, Vaughan L, Wang WC, Unger E, Henderson BW. Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br J Cancer 2003;88:1772-9. Go to original source... Go to PubMed...
  20. Seshadri M, Bellnier DA. The vascular disrupting agent 5,6-dimethylxanthenone- 4-acetic acid improves the antitumor efficacy and shortens treatment time associated with Photochlor-sensitized photodynamic therapy in vivo. Photochem Photobiol 2009;85:50-6. Go to original source... Go to PubMed...
  21. Yom SS, Busch TM, Friedberg JS, Wileyto EP, Smith D, Glatstein E, Hahn SM. Elevated serum cytokine levels in mesothelioma patients who have undergone pleurectomy or extrapleural pneumonectomy and adjuvant intraoperative photodynamic therapy. Photochem Photobiol 2003;78:75-81. Go to original source... Go to PubMed...
  22. Korbelik M, Sun J, Cecic I. Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. Cancer Res 2005;65:1018-26. Go to PubMed...
  23. Kushibiki T, Tajiri T, Tomioka Y, Awazu K. Photodynamic therapy induces interleukin secretion from dendritic cells. Int J Clin Exp Med 2010;3:110-4. Go to PubMed...
  24. Castano AP, Mroz P, Hamblin MR. Photodynamic therapy and antitumour immunity. Nat Rev Cancer 2006;6:535-45. Go to original source... Go to PubMed...
  25. Garg AD, Nowis D, Goł±b J, Agostinis P. Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity. Apoptosis 2010;15:1050-71. Go to original source... Go to PubMed...
  26. Firczuk M, No wis D, Goł±b J. PDT-induced inflammatory and host responses. Photochem Photobiol Sci 2011;10:653-63. Go to original source... Go to PubMed...
  27. Cecic I, Korbelik M. Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors. Cancer Lett 2002;183:43-51. Go to original source... Go to PubMed...
  28. Cecic I, Parkins CS, Korbelik M. Induction of systemic neutrophil response in mice by photodynamic therapy of solid tumors. Photochem Photobiol 2001;74:712-20. Go to original source... Go to PubMed...
  29. Cecic I, Sun J, Korbelik M. Role of complement anaphylatoxin C3a in photodynamic therapy-elicited engagement of host neutrophils and other immune cells. Photochem Photobiol 2006a;82:558-62. Go to original source... Go to PubMed...
  30. Dunkelberger JR, Song WC. Complement and its role in innate and adaptive immune responses. Cell Res 2010;20:34-50. Go to original source... Go to PubMed...
  31. Tegla CA, Cudrici C, Patel S, Trippe R 3rd, Rus V, Niculescu F, Rus H. Membrane attack by complement: the assembly and biology of terminal complement complexes. Immunol Res 2011;51:45-60. Go to original source... Go to PubMed...
  32. Korbelik M, Sun J, Cecic I, Serrano K. Adjuvant treatment for complement activation increases the effectiveness of photodynamic therapy of solid tumors. Photochem Photobiol Sci 2004;3:812-6. Go to original source... Go to PubMed...
  33. Cecic I, Serrano K, Gyongyossy-Issa M, Korbelik M. Characteristics of complement activation in mice bearing Lewis lung carcinomas treated by photodynamic therapy. Cancer Lett 2005;225:215-23. Go to original source... Go to PubMed...
  34. Korbelik M. Complement upregulation in photodynamic therapytreated tumors: Role of Toll-like receptor pathway and NFkappaB. Cancer Lett 2009;281:232-8. Go to original source... Go to PubMed...
  35. van Duijnhoven FH, Aalbers RI, Rovers JP, Terpstra OT, Kuppen PJ. The immunological consequences of photodynamic treatment of cancer, a literature review. Immunobiology 2003; 207:105-13. Go to original source... Go to PubMed...
  36. Cecic I, Stott B, Korbelik M. Acute phase response-associated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy. Int Immunopharmacol 2006b;6:1259-66. Go to original source... Go to PubMed...
  37. Cecic I, Minchinton AI, Korbelik M. The impact of complement activation on tumor oxygenation during photodynamic therapy. Photochem Photobiol 2007;83:1049-55. Go to original source... Go to PubMed...
  38. Cecic I, Korbelik M. Deposition of complement proteins on cells treated by photodynamic therapy in vitro. J Environ Pathol Toxicol Oncol 2006;25:189-203. Go to original source... Go to PubMed...
  39. Stott B, Korbelik M. Activation of complement C3, C5, and C9 genes in tumors treated by photodynamic therapy. Cancer Immunol Immunother 2007;56:649-58. Go to original source... Go to PubMed...
  40. Korbelik M, Cec ic I Complement activation cascade and its regulation: relevance for the response of solid tumors to photodynamic therapy. J Photochem Photobiol B 2008;93:53-9. Go to original source... Go to PubMed...
  41. Morgan BP, Marc hbank KJ, Longhi MP, Harris CL, Gallimore AM. Complement: central to innate immunity and bridging to adaptive responses, Immunol Lett 2005;97:171-9. Go to original source... Go to PubMed...
  42. Kemper C, Atkin son JP. T-cell regulation: with complements from innate immunity, Nat Rev Immunol 2007;7:9-18. Go to original source... Go to PubMed...
  43. Preise D, Oren R, Glinert I, Kalchenko V, Jung S, Scherz A, Salomon Y. Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity. Cancer Immunol Immunother 2009;58:71-84. Go to original source... Go to PubMed...
  44. Kabingu E, Vaughan L, Owczarczak B, Ramsey KD, Gollnick SO. CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells. Br J Cancer 2007;96:1839-48. Go to original source... Go to PubMed...
  45. Thong PS, Ong KW, Goh NS, Kho KW, Manivasager V, Bhuvaneswari R, Olivo M, Soo KC. Photodynamic-therapy-activated immune response against distant untreated tumours in recurrent angiosarcoma. Lancet Oncol 2007;8:950-2. Go to original source... Go to PubMed...
  46. Kabingu E, Oseroff AR, Wilding GE, Gollnick SO. Enhanced systemic immune reactivity to a Basal cell carcinoma associated antigen following photodynamic therapy. Clin Cancer Res 2009;15:4460-6. Go to original source... Go to PubMed...
  47. Elmets CA, Bowe n KD. Immunological suppression in mice treated with hematoporphyrin derivative photoradiation. Cancer Res 1986;46:1608-11. Go to PubMed...
  48. Musser DA, Oseroff AR. Characteristics of the immunosuppression induced by cutaneous photodynamic therapy: persistence, antigen specificity and cell type involved. Photochem Photobiol 2001;73:518-24. Go to original source... Go to PubMed...
  49. Gollnick SO, Musser DA, Oseroff AR, Vaughan L, Owczarczak B, Henderson BW. IL-10 does not play a role in cutaneous Photofrin photodynamic therapy-induced suppression of the contact hypersensitivity response. Photochem Photobiol 2001b;74:811-6. Go to original source... Go to PubMed...
  50. Hayami J, Okamoto H, Sugihara A, Horio T. Immunosuppressive effects of photodynamic therapy by topical aminolevulinic acid. J Dermatol 2007;34:320-7. Go to original source... Go to PubMed...
  51. Yusuf N, Katiyar SK, Elmets CA. The immunosuppressive effects of phthalocyanine photodynamic therapy in mice are mediated by CD4+ and CD8+ T cells and can be adoptively transferred to naive recipients. Photochem Photobiol 2008;84(2):366-70. Go to original source... Go to PubMed...
  52. Matthews YJ, Damian DL. Topical photodynamic therapy is immunosuppressive in humans. Br J Dermatol 2010;162:637-41. Go to original source... Go to PubMed...
  53. Hunt DW, Levy JG. Immunomodulatory aspects of photodynamic therapy. Expert Opin Investig Drugs 1998;7:57-64. Go to original source... Go to PubMed...
  54. Qiang YG, Yow CM, Huang Z. Combination of photodynamic therapy and immunomodulation: current status and future trends. Med Res Rev 2008;28:632-44. Go to original source... Go to PubMed...
  55. Kwitniewski M, Juzeniene A, Glosnicka R, Moan J. Immunotherapy: a way to improve the therapeutic outcome of photodynamic therapy? Photochem Photobiol Sci 2008;7:1011-7. Go to original source... Go to PubMed...
  56. Goł±b J, Wilczyński G, Zagożdżon R, Stokłosa T, Dabrowska A, Rybczyńska J, W±sik M, Machaj E, Ołdak T, Kozar K, Kamiński R, Giermasz A, Czajka A, Lasek W, Feleszko W, Jakóbisiak M. Potentiation of the anti-tumour effects of Photofrin-based photodynamic therapy by localized treatment with G-CSF. Br J Cancer 2000;82:1485-91. Go to original source... Go to PubMed...
  57. Bellnier DA. Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factor-alpha. J Photochem Photobiol B 1991;8:203-10. Go to original source... Go to PubMed...
  58. Bellnier DA, Gollnick SO, Camacho SH, Greco WR, Cheney RT. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors. Cancer Res 2003;63:7584-90. Go to PubMed...
  59. Seshadri M, Spernyak JA, Mazurchuk R, Camacho SH, Oseroff AR, Cheney RT, Bellnier DA. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4- acetic acid: implications for combination therapy. Clin Cancer Res 2005;11:4241-50. Go to original source... Go to PubMed...
  60. Korbelik M, Cooper PD. Potentiation of photodynamic therapy of cancer by complement: the effect of gamma-inulin. Br J Cancer 2007;96:67-72. Go to original source... Go to PubMed...
  61. Akramiene D, Aleksandraviciene C, Grazeliene G, Zalinkevicius R, Suziedelis K, Didziapetriene J, Simonsen U, Stankevicius E, Kevelaitis E. Potentiating effect of beta-glucans on photodynamic therapy of implanted cancer cells in mice. Tohoku J Exp Med 2010;220:299-306. Go to original source... Go to PubMed...
  62. Separovic D, Bielawski J, Pierce JS, Merchant S, Tarca AL, Bhatti G, Ogretmen B, Korbelik M. Enhanced tumor cures after Foscan photodynamic therapy combined with the ceramide analog LCL29. Evidence from mouse squamous cell carcinomas for sphingolipids as biomarkers of treatment response. Int J Oncol 2011;38:521-7. Go to original source... Go to PubMed...
  63. Coupienne I, Bontems S, Dewaele M, Rubio N, Habraken Y, Fulda S, Agostinis P, Piette J. NF-kappaB inhibition improves the sensitivity of human glioblastoma cells to 5- aminolevulinic acid-based photodynamic therapy. Biochem Pharmacol 2011;81:606-16. Go to original source... Go to PubMed...
  64. Mew D, Wat CK, Towers GH, Levy JG. Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibodyhematoporphyrin conjugates. J Immunol 1983;130:1473-7. Go to PubMed...
  65. Hasan T. Phot osensitizer delivery mediated by macromolecular carrier systems. In: Henderson BW, Dougherty TJ, editor. Photodynamic therapy: basic principles and clinical applications. New York: Marcel Dekker, Inc; 1992. p.187-200.
  66. Sternberg ED, Dolphin D, Brückner C. Porphyrinbased photosensitizers for use in photodynamic therapy. Tetrahedron 1998;54:4151-202. Go to original source...
  67. Yarmush ML, Thorpe WP, Strong L, Rakestraw SL, Toner M, Tompkins RG. Antibody Targeted Photolysis. Crit Rev Ther Drug Carrier Syst 1993;10:197-252. Go to PubMed...
  68. Savellano MD, Hasan T. Targeting cells that overexpress the epidermal growth factor receptor with polyethylene glycolated BPD verteporfin photosensitizer immunoconjugates. Photochem Photobiol 2003;77:431-9. Go to original source... Go to PubMed...
  69. Savellano MD, Pogue BW, Hoopes PJ, Vitetta ES, Paulsen KD. Multiepitope HER2 targeting enhances photoimmunotherapy of HER2-overexpressing cancer cells with pyropheophorbide-a immunoconjugates. Cancer Res 2005;65:6371-9. Go to original source... Go to PubMed...
  70. Bhatti M, Yahioglu G, Milgrom LR, Garcia-Maya M, Chester KA, Deonarain MP. Targeted photodynamic therapy with multiply-loaded recombinant antibody fragments. Int J Cancer 2008;122:1155-63. Go to original source... Go to PubMed...
  71. Jalili A, Makowski M, Switaj T, Nowis D, Wilczynski GM, Wilczek E, Chorazy-Massalska M, Radzikowska A, Maslinski W, Biały L, Sienko J, Sieron A, Adamek M, Basak G, Mróz P, Krasnodebski IW, Jakóbisiak M, Gołab J. Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells. Clin Cancer Res 2004;10:4498-508. Go to original source... Go to PubMed...
  72. Saji H, Song W, Furumoto K, Kato H, Engleman EG. Systemic antitumor effect of intratumoral injection of dendritic cells in combination with local photodynamic therapy. Clin Cancer Res 2006;12:2568-74. Go to original source... Go to PubMed...
  73. del Carmen MG, Rizvi I, Chang Y, Moor AC, Oliva E, Sherwood M, Pogue B, Hasan T. Synergism of epidermal growth factor receptortargeted immunotherapy with photodynamic treatment of ovarian cancer in vivo. Natl Cancer Inst 2005;97:1516-24. Go to original source... Go to PubMed...
  74. Jiang F, Zhang X, Kalkanis SN, Zhang Z, Yang H, Katakowski M, Hong X, Zheng X, Zhu Z, Chopp M. Combination therapy with antiangiogenic treatment and photodynamic therapy for the nude mouse bearing U87 glioblastoma. Photochem Photobiol 2008;84:128-37. Go to original source... Go to PubMed...
  75. Bhuvaneswari R, Thong PS, Gan YY, Soo KC, Olivo M. Evaluation of hypericin-mediated photodynamic therapy in combination with angiogenesis inhibitor bevacizumab using in vivo fluorescence confocal endomicroscopy. J Biomed Opt 2010;15:011114. Go to original source... Go to PubMed...
  76. Korbelik, M., Sun, J. Photodynamic therapy-generated vaccine for cancer therapy. Cancer Immunol Immunother 2006;55:900-9. Go to original source... Go to PubMed...
  77. Korbelik M. Photodynamic therapy-generated cancer vaccines. Methods Mol Biol 2010;635:147-53. Go to original source... Go to PubMed...
  78. Korbelik M, Stott B, Sun J. Photodynamic therapy-generated vaccines: relevance of tumour cell death expression. Br J Cancer 2007;97:1381-7. Go to original source... Go to PubMed...
  79. Zhang H, Ma W, Li Y. Generation of effective vaccines against liver cancer by using photodynamic therapy. Lasers Med Sci 2009;24:549- 52. Go to original source... Go to PubMed...
  80. Shixiang Y, Xi S, Junliang L, Shanyi Z, Xingke X, Meiguang Z, Kai W, Fangcheng L. Antitumor efficacy of a photodynamic therapy-generated dendritic cell glioma vaccine. Med Oncol 2010 [Epub ahead of print] doi:10.1007/s12032-010-9713-y

Return to the content